BREAKING NEWS - What Does the FDA Hold on the Pacritinib Trial Mean?

BREAKING NEWS - What Does the FDA Hold on the Pacritinib Trial Mean?

P2Professional

4 years
322 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
In February 2016, the FDA placed a full clinical hold on the trials for the MPN treatment pacritinib. To find out more, we reached out to one of the principal investigators for the trial, Dr. Ruben Mesa from the Mayo Clinic in Arizona. Watch as Dr. Mesa helps patients to understand why the FDA places holds on trials from time to time, particularly related to the pacritinib trial. He also shares guidance specifically for patients that may have been on the trial and how they should move forward.

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo
Up Next Autoplay